CME Group Director Daniel Kaye Receives 645 Shares in Annual Equity Compensation

This Form 4 filing reports that Daniel G. Kaye, a director of CME Group Inc., received 645 shares of Class A Common Stock on June 25, 2026, as part of the company's annual equity compensation program for non-employee directors. The shares were granted under the CME Group Director Stock Plan and are fully vested with no vesting conditions. The transaction was priced at $225 per share, bringing Kaye's total holdings to 4,845 shares. The filing includes a power of attorney document authorizing company representatives to file Section 16 reports on Kaye's behalf. This represents routine director compensation rather than a market transaction.